Analysis shows a 25% increase in U.S. private insurer prescription drug denials from 2016-2023, driven by rising drug costs and claim automation. Insights into industry impact and reform efforts.

Prescription drug denials by private insurers rise 25% (2016-2023). Sarepta gene therapy linked to patient deaths. ICE gains Medicaid data access. ACA insurers seek 2026 rate hikes. Implications for U.S. insurance, regulatory compliance, and patient access.

Oscar Health's innovative routing technology is driving claims deflation and profitability, reshaping healthcare delivery and insurance cost management in the U.S. market.

Maris Kreizman shares insights on the evolving U.S. publishing industry, freelance writing challenges, health insurance issues for creatives, and critiques of corporate media structures.

Research reveals immune checkpoint inhibitors improve cancer survival rates but widen insurance-based disparities. Expanding health coverage may mitigate gaps in treatment outcomes.

New Affordable Care Act regulations may reduce health insurance coverage for 14,000 Illinois residents, impacting Medicaid access and insurance market dynamics.

Wells Fargo and Barclays downgrade Oscar Health citing rising medical expenses and pricing concerns for 2025, highlighting potential challenges in sustaining profitability.

The $50 billion Rural Health Transformation Program aims to strengthen rural health care but faces challenges in implementation and funding amid federal Medicaid cuts, impacting states, providers, and rural communities.

Priority Health expands beyond traditional coverages by embracing whole-person care and digital partnerships, addressing chronic conditions and simplifying member navigation in health plans.

Explore essential strategies for federal employees facing workforce cuts, focusing on health insurance transitions, retirement savings options, and benefits continuity.